Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Bone Marrow Transplant ; 38(11): 733-8, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17028624

ABSTRACT

Umbilical cord blood transplant (UCBT) has emerged as an alternate source of stem cells for transplantation in patients with hematologic malignancies. However, outcomes of adult UCBT patients requiring ICU admission remain unknown. In order to identify predictors of ICU transfer and mortality in UCBT patients, the course and outcome of all adult (> or = 16 years old) patients who underwent UCBT between 1 January 1998 and 31 December 2003 at University Hospitals of Cleveland were analyzed. Forty-four patients underwent UCBT during the study period and 25 (57%) required ICU transfer. Use of a myeloablative preparative regimen was a significant predictor of ICU transfer (P = 0.03). An infusion of higher numbers of nucleated cells was protective from ICU transfer (P = 0.05). For those patients transferred to the ICU, mortality was 72%. The univariate predictors of mortality, at the time of ICU admission were a high APACHE III score (P = 0.0004), use of vasopressors (P = 0.03), and a low platelet count (P = 0.03). We conclude that transfer of UCBT patients to an ICU may be predicted by their preparative regimen, while ICU mortality may be predicted by physiologic parameters upon admission.


Subject(s)
Cord Blood Stem Cell Transplantation/adverse effects , Hematologic Neoplasms/therapy , Intensive Care Units , APACHE , Adolescent , Adult , Aged , Cord Blood Stem Cell Transplantation/mortality , Female , Hospitals, University/statistics & numerical data , Humans , Male , Middle Aged , Myeloablative Agonists/adverse effects , Patient Admission/statistics & numerical data , Platelet Count , Prognosis , Retrospective Studies , Risk Factors , Survival Analysis , Thrombocytopenia , Transplantation, Homologous , Treatment Outcome , Vasoconstrictor Agents/therapeutic use
2.
Diabetes ; 40(4): 465-71, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2010046

ABSTRACT

Early functional disturbances in nerve, retina, and lens in diabetes mellitus appear to result from a common mechanism involving increased polyol-pathway activity with an associated effect on tissue myo-inositol metabolism. We tested the role of increased polyol-pathway activity in the early glomerular hemodynamic abnormalities in experimental diabetes in rats with dietary myo-inositol supplementation or the administration of sorbinil, an aldose reductase inhibitor. Each maneuver prevented the glomerular hyperfiltration of early streptozocin-induced diabetes and reversed the hyperfiltration of established diabetes of 10 days' duration. We also found that the abnormal response to captopril in diabetic rats was improved by dietary myo-inositol supplementation or sorbinil administration. Although nonhypotensive doses of captopril lowered glomerular filtration rate (GFR) in diabetic rats on a 0.01% myo-inositol diet, GFR increased substantially after captopril infusion in diabetic rats treated with sorbinil or myo-inositol supplementation. These data suggest that normalization of tissue myo-inositol metabolism restores normal responsiveness to angiotensin II; this may contribute to the reduction in GFR with the two experimental maneuvers. We also tested the interaction between polyol-pathway activation and high dietary protein intake. Aldose reductase inhibition and dietary myo-inositol supplementation had no effect on the component of increased GFR due to 50% dietary protein intake but specifically inhibited the hyperfiltration attributable to diabetes. These results suggest that hyperglycemia acts through increased polyol-pathway activity and its effects on tissue myo-inositol metabolism to play a fundamental role in the pathogenesis of the glomerular hyperfiltration characteristic of early diabetes.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Glomerular Filtration Rate/drug effects , Imidazolidines , Inositol/pharmacology , Kidney Glomerulus/blood supply , Sugar Alcohols/metabolism , Animals , Blood Glucose/metabolism , Blood Pressure/drug effects , Captopril/pharmacology , Diet , Dietary Proteins/pharmacology , Imidazoles/pharmacology , Inositol/administration & dosage , Inositol/blood , Male , Rats , Rats, Inbred Strains , Reference Values , Regional Blood Flow/drug effects
3.
Kidney Int ; 35(6): 1345-50, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2671467

ABSTRACT

A prospective study of 14 patients (ages 6 months to 33 years) with glycogen storage disease, Type I (GSD-I) was carried out in order to define the character and frequency of renal dysfunction. A marked increase in the glomerular filtration rate (GFR) was documented in virtually all subjects, with the mean GFR raised by approximately 50%, to the range of 170 ml/min/1.73 m2. While this constituted the only renal abnormality found in the younger patients, a significant increase in urinary albumin excretion was seen in three teen-aged individuals; three patients over 20 years of age exhibited frank proteinuria (2 to 8 g/day). Renal biopsy on two of the proteinuric subjects revealed focal and global glomerulosclerosis and interstitial fibrosis. Evaluation of factors known to cause an increase in GFR did not define the precise etiology for its elevation in GSD-I. These studies suggest that: (1) glomerular damage and chronic renal disease are common in older patients with GSD-I; (2) the renal injury appears to be specifically related to GSD-I and is not secondary to the treatment of the disease; and (3) the natural history of the renal lesion in GSD-I may be analogous to that seen in insulin-dependent diabetes, with a "silent" period where hyperfiltration is the only demonstrable renal abnormality, followed by evidence of increasing glomerular damage progressing from microalbuminuria to frank proteinuria.


Subject(s)
Glomerular Filtration Rate , Glycogen Storage Disease Type I/physiopathology , Kidney Diseases/etiology , Adolescent , Adult , Albuminuria , Child , Child, Preschool , Creatinine/metabolism , Female , Glycogen Storage Disease Type I/complications , Humans , Infant , Inulin , Kidney/pathology , Male , Organometallic Compounds , Pentetic Acid , Prospective Studies , Technetium Tc 99m Pentetate
4.
J Clin Invest ; 77(2): 503-13, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3003162

ABSTRACT

To determine whether basal phosphoinositide turnover plays a role in metabolic regulation in resting rabbit aortic intima-media incubated under steady state conditions, we used deprivation of extracellular myo-inositol as a potential means of inhibiting basal phosphatidylinositol (PI) synthesis at restricted sites and of depleting small phosphoinositide pools with a rapid basal turnover. Medium myo-inositol in a normal plasma level was required to prevent inhibition of a specific component of basal de novo PI synthesis that is necessary to demonstrate a discrete rapidly turning-over [1,3-14C]glycerol-labeled PI pool. Medium myo-inositol was also required to label the discrete PI pool with [1-14C]arachidonic acid (AA). The rapid basal turnover of this PI pool, when labeled with glycerol or AA, was not attributable to its utilization for polyphosphoinositide formation, and it seems to reflect basal PI hydrolysis. Depleting endogenous free AA with medium defatted albumin selectively inhibits the component of basal de novo PI synthesis that replenishes the rapidly turning-over PI pool. A component of normal resting energy utilization in aortic intima-media also specifically requires medium myo-inositol in a normal plasma level and a free AA pool; its magnitude is unaltered by indomethacin, nordihydroguaiaretic acid, or Ca2+-free medium. This energy utilization results primarily from Na+/K+ ATPase activity (ouabain-inhibitable O2 consumption), and in Ca2+-free medium deprivation of medium myo-inositol or of free AA inhibits resting Na+/K+ ATPase activity to a similar degree (60%, 52%). In aortic intima-media basal PI turnover controls a major fraction of resting Na+/K+ ATPase activity.


Subject(s)
Aorta/enzymology , Phosphatidylinositols/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Arachidonic Acid , Arachidonic Acids/metabolism , Energy Metabolism , Glycerol/metabolism , Hydrolysis , Inositol/physiology , Kinetics , Male , Oxygen Consumption , Phosphatidylinositols/biosynthesis , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...